Sunstone Life Science Ventures, based in Copenhagen, is a venture capital fund focusing on early-stage biotech and health tech investments, specifically in seed and Series A rounds. They aim to improve patient outcomes and support companies like MinervaX and Resalis Therapeutics. With a team experienced in startups, corporate management, and finance, Sunstone assists portfolio companies with strategic and operational challenges. Backed by InnovFin Equity, the EU's Horizon 2020 Financial Instruments, and the European Fund for Strategic Investments, Sunstone Life Science Ventures plays a crucial role in advancing European life sciences.
